Interleukin 33: An innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer

European Journal of Immunology

Volumn 46, Issue 5, 2016, Pages 1091-1100

  Schwartz, Christian ^a   O'Grady, Katie ^b   Lavelle, Ed C ^b   Fallon, Padraic G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cytokines; Immune regulation; Innate immunity; Interleukin 33

Indexed keywords

INTERLEUKIN 33; ALARMIN; CYTOKINE; IL33 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; BIOCHEMISTRY; CARCINOGENESIS; ENTERITIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; NEOPLASM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; TH2 CELL; TISSUE INJURY; ANIMAL; IMMUNOLOGY; NEOPLASMS;

ADAPTIVE IMMUNITY; ALARMINS; ANIMALS; CYTOKINES; ENTERITIS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-33; NEOPLASMS; OBESITY; TH2 CELLS;

EID: 84963685500     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545780     Document Type: Article

References (95)

1. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479-490.
2. Carriere, V., Roussel, L., Ortega, N., Lacorre, D. A., Americh, L., Aguilar, L., Bouche, G. et al., IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 2007. 104: 282-287.
3. Roussel, L., Erard, M., Cayrol, C. and Girard, J. P., Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep. 2008. 9: 1006-1012.
4. Ali, S., Mohs, A., Thomas, M., Klare, J., Ross, R., Schmitz, M. L. and Martin, M. U., The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J. Immunol. 2011. 187: 1609-1616.
5. Lingel, A., Weiss, T. M., Niebuhr, M., Pan, B., Appleton, B. A., Wiesmann, C., Bazan, J. F. et al., Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 2009. 17: 1398-1410.
6. Liu, X., Hammel, M., He, Y., Tainer, J. A., Jeng, U. S., Zhang, L., Wang, S. et al., Structural insights into the interaction of IL-33 with its receptors. Proc. Natl. Acad. Sci. USA 2013. 110: 14918-14923.
7. Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N. and Girard, J. P., Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 2012. 188: 3488-3495.
8. Cayrol, C. and Girard, J. P., The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 2009. 106: 9021-9026.
9. Moussion, C., Ortega, N. and Girard, J. P., The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008. 3: e3331.
10. Kouzaki, H., Iijima, K., Kobayashi, T., O'Grady, S. M. and Kita, H., The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J. Immunol. 2011. 186: 4375-4387.
11. Bessa, J., Meyer, C. A., de Vera Mudry, M. C., Schlicht, S., Smith, S. H., Iglesias, A. and Cote-Sierra, J., Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. J. Autoimmunol. 2014. 55: 33-41.
12. Ohto-Ozaki, H., Kuroiwa, K., Mato, N., Matsuyama, Y., Hayakawa, M., Tamemoto, H. and Tominaga, S., Characterization of ST2 transgenic mice with resistance to IL-33. Eur. J. Immunol. 2010. 40: 2632-2642.
13. Bulek, K., Swaidani, S., Qin, J., Lu, Y., Gulen, M. F., Herjan, T., Min, B., Kastelein, R. A. et al., The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. J. Immunol. 2009. 182: 2601-2609.
14. Afonina, I. S., Muller, C., Martin, S. J. and Beyaert, R., Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 2015. 42: 991-1004.
15. Talabot-Ayer, D., Lamacchia, C., Gabay, C. and Palmer, G., Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 2009. 284: 19420-19426.
16. Luthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G. et al., Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009. 31: 84-98.
17. Cohen, E. S., Scott, I. C., Majithiya, J. B., Rapley, L., Kemp, B. P., England, E., Rees, D. G. et al., Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat. Commun. 2015. 6: 8327.
18. Lefrancais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J. P. and Cayrol, C., IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. USA 2012. 109: 1673-1678.
19. Bae, S., Kang, T., Hong, J., Lee, S., Choi, J., Jhun, H., Kwak, A. et al., Contradictory functions (activation/termination) of neutrophil proteinase 3 enzyme (PR3) in interleukin-33 biological activity. J. Biol. Chem. 2012. 287: 8205-8213.
20. Waern, I., Lundequist, A., Pejler, G. and Wernersson, S., Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation. Mucosal Immunol. 2013. 6: 911-920.
21. Roy, A., Ganesh, G., Sippola, H., Bolin, S., Sawesi, O., Dagalv, A., Schlenner, S. M. et al., Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation. J. Biol. Chem. 2014. 289: 237-250.
22. Lefrancais, E., Duval, A., Mirey, E., Roga, S., Espinosa, E., Cayrol, C. and Girard, J. P., Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc. Natl. Acad. Sci. USA 2014. 111: 15502-15507.
23. Enoksson, M., Lyberg, K., Moller-Westerberg, C., Fallon, P. G., Nilsson, G. and Lunderius-Andersson, C., Mast cells as sensors of cell injury through IL-33 recognition. J. Immunol. 2011. 186: 2523-2528.
24. Saluja, R., Khan, M., Church, M. K. and Maurer, M., The role of IL-33 and mast cells in allergy and inflammation. Clin. Transl. Allergy 2015. 5: 33. eCollection 2015.
25. Ito, T., Egusa, C., Maeda, T., Numata, T., Nakano, N., Nishiyama, C. and Tsuboi, R., IL-33 promotes MHC class II expression in murine mast cells. Immun. Inflamm. Dis. 2015. 3: 196-208.
26. Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J. et al., Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010. 463: 540-544.
27. McKenzie, A. N., Spits, H. and Eberl, G., Innate lymphoid cells in inflammation and immunity. Immunity 2014. 41: 366-374.
28. Nussbaum, J. C., Van Dyken, S. J., von Moltke, J., Cheng, L. E., Mohapatra, A., Molofsky, A. B., Thornton, E. E. et al., Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013. 502: 245-248.
29. Molofsky, A. B., Nussbaum, J. C., Liang, H. E., Van Dyken, S. J., Cheng, L. E., Mohapatra, A., Chawla, A. et al., Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 2013. 210: 535-549.
30. Hung, L. Y., Lewkowich, I. P., Dawson, L. A., Downey, J., Yang, Y., Smith, D. E. and Herbert, D. R., IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc. Natl. Acad. Sci. USA 2013. 110: 282-287.
31. Van Dyken, S. J., Mohapatra, A., Nussbaum, J. C., Molofsky, A. B., Thornton, E. E., Ziegler, S. F., McKenzie, A. N. et al., Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and gammadelta T cells. Immunity 2014. 40: 414-424.
32. Yasuda, K., Muto, T., Kawagoe, T., Matsumoto, M., Sasaki, Y., Matsushita, K., Taki, Y. et al., Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl. Acad. Sci. USA 2012. 109: 3451-3456.
33. Chang, Y. J., Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N., Smith, D. E., Dekruyff, R. H. et al., Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 2011. 12: 631-638.
34. Monticelli, L. A., Sonnenberg, G. F., Abt, M. C., Alenghat, T., Ziegler, C. G., Doering, T. A., Angelosanto, J. M. et al., Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 2011. 12: 1045-1054.
35. Byers, D. E., Alexander-Brett, J., Patel, A. C., Agapov, E., Dang-Vu, G., Jin, X., Wu, K. et al., Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J. Clin. Invest. 2013. 123: 3967-3982.
36. Bouffi, C., Rochman, M., Zust, C. B., Stucke, E. M., Kartashov, A., Fulkerson, P. C., Barski, A. et al., IL-33 markedly activates murine eosinophils by an NF-kappaB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. J. Immunol. 2013. 191: 4317-4325.
37. Schwartz, C., Willebrand, R., Huber, S., Rupec, R. A., Wu, D., Locksley, R. and Voehringer, D., Eosinophil-specific deletion of IkappaBalpha in mice reveals a critical role of NF-kappaB-induced Bcl-xL for inhibition of apoptosis. Blood 2015. 125: 3896-3904.
38. Oliphant, C. J., Hwang, Y. Y., Walker, J. A., Salimi, M., Wong, S. H., Brewer, J. M., Englezakis, A. et al., MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014. 41: 283-295.
39. Halim, T. Y., Hwang, Y. Y., Scanlon, S. T., Zaghouani, H., Garbi, N., Fallon, P. G. and McKenzie, A. N., Group 2 innate lymphoid cells license dendritic cells to potentiate memory T2 cell responses. Nat. Immunol. 2016. 17: 57-64.
40. Moro, K., Kabata, H., Tanabe, M., Koga, S., Takeno, N., Mochizuki, M., Fukunaga, K. et al., Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat. Immunol. 2016. 17: 76-86.
41. Duerr, C. U., McCarthy, C. D., Mindt, B. C., Rubio, M., Meli, A. P., Pothlichet, J., Eva, M. M. et al., Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat. Immunol. 2016. 17: 65-75.
42. Yang, Z., Grinchuk, V., Urban, J. F., Jr., Bohl, J., Sun, R., Notari, L., Yan, S. et al., Macrophages as IL-25/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS One 2013. 8: e59441.
43. Li, D., Guabiraba, R., Besnard, A. G., Komai-Koma, M., Jabir, M. S., Zhang, L., Graham, G. J. et al., IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J. Allergy Clin. Immunol. 2014. 134: 1422-1432 e1411.
44. Huber, S., Hoffmann, R., Muskens, F. and Voehringer, D., Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood 2010. 116: 3311-3320.
45. Schneider, E., Petit-Bertron, A. F., Bricard, R., Levasseur, M., Ramadan, A., Girard, J. P., Herbelin, A. et al., IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J. Immunol. 2009. 183: 3591-3597.
46. Kroeger, K. M., Sullivan, B. M. and Locksley, R. M., IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway. J. Leukoc. Biol. 2009. 86: 769-778.
47. Rivellese, F., Suurmond, J., de Paulis, A., Marone, G., Huizinga, T. W. and Toes, R. E., IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation. Eur. J. Immunol. 2014. 44: 3045-3055.
48. Rank, M. A., Kobayashi, T., Kozaki, H., Bartemes, K. R., Squillace, D. L. and Kita, H., IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol. 2009. 123: 1047-1054.
49. Besnard, A. G., Togbe, D., Guillou, N., Erard, F., Quesniaux, V. and Ryffel, B., IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol. 2011. 41: 1675-1686.
50. Matta, B. M., Lott, J. M., Mathews, L. R., Liu, Q., Rosborough, B. R., Blazar, B. R. and Turnquist, H. R., IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J. Immunol. 2014. 193: 4010-4020.
51. Endo, Y., Hirahara, K., Iinuma, T., Shinoda, K., Tumes, D. J., Asou, H. K., Matsugae, N. et al., The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway. Immunity 2015. 42: 294-308.
52. Smithgall, M. D., Comeau, M. R., Yoon, B. R., Kaufman, D., Armitage, R. and Smith, D. E., IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 2008. 20: 1019-1030.
53. Bourgeois, E., Van, L. P., Samson, M., Diem, S., Barra, A., Roga, S., Gombert, J. M. et al., The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 2009. 39: 1046-1055.
54. Molofsky, A. B., Van Gool, F., Liang, H. E., Van Dyken, S. J., Nussbaum, J. C., Lee, J., Bluestone, J. A. et al., Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 2015. 43: 161-174.
55. Baumann, C., Bonilla, W. V., Frohlich, A., Helmstetter, C., Peine, M., Hegazy, A. N., Pinschewer, D. D. et al., T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses. Proc. Natl. Acad. Sci. USA 2015. 112: 4056-4061.
56. Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., Fagarasan, S. et al., The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 2015. 16: 276-285.
57. Newcomb, D. C., Zhou, W., Moore, M. L., Goleniewska, K., Hershey, G. K., Kolls, J. K. and Peebles, R. S., Jr., A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production. J. Immunol. 2009. 182: 5317-5321.
58. Yang, Q., Li, G., Zhu, Y., Liu, L., Chen, E., Turnquist, H., Zhang, X. et al., IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur. J. Immunol. 2011. 41: 3351-3360.
59. Bonilla, W. V., Frohlich, A., Senn, K., Kallert, S., Fernandez, M., Johnson, S., Kreutzfeldt, M. et al., The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses. Science 2012. 335: 984-989.
60. Villarreal, D. O., Wise, M. C., Walters, J. N., Reuschel, E. L., Choi, M. J., Obeng-Adjei, N., Yan, J. et al., Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity. Cancer Res. 2014. 74: 1789-1800.
61. Komai-Koma, M., Gilchrist, D. S., McKenzie, A. N., Goodyear, C. S., Xu, D. and Liew, F. Y., IL-33 activates B1 cells and exacerbates contact sensitivity. J. Immunol. 2011. 186: 2584-2591.
62. Sattler, S., Ling, G. S., Xu, D., Hussaarts, L., Romaine, A., Zhao, H., Fossati-Jimack, L. et al., IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut. J. Autoimmun. 2014. 50: 107-122.
63. O'Reilly, S., Role of interleukin-13 in fibrosis, particularly systemic sclerosis. Biofactors 2013. 39: 593-596.
64. Horikawa, K. and Takatsu, K., Interleukin-5 regulates genes involved in B-cell terminal maturation. Immunology 2006. 118: 497-508.
65. Morawetz, R. A., Gabriele, L., Rizzo, L. V., Noben-Trauth, N., Kuhn, R., Rajewsky, K., Muller, W. et al., Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse. J. Exp. Med. 1996. 184: 1651-1661.
66. Molofsky, A. B., Savage, A. K. and Locksley, R. M., Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity 2015. 42: 1005-1019.
67. Wensveen, F. M., Valentic, S., Sestan, M., Turk Wensveen, T. and Polic, B., The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation. Eur. J. Immunol. 2015. 45: 2446-2456.
68. Hams, E., Bermingham, R., Wurlod, F. A., Hogan, A. E., O'Shea, D., Preston, R. J., Rodewald, H. R. et al., The helminth T2 RNase omega1 promotes metabolic homeostasis in an IL-33 and group 2 innate lymphoid cell-dependent mechanism. FASEB J. 2016. 30(2): 824-835.
69. Wood, I. S., Wang, B. and Trayhurn, P., IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem. Biophys. Res. Commun. 2009. 384: 105-109.
70. Lee, M. W., Odegaard, J. I., Mukundan, L., Qiu, Y., Molofsky, A. B., Nussbaum, J. C., Yun, K. et al., Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 2015. 160: 74-87.
71. Wu, D., Molofsky, A. B., Liang, H. E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A. et al., Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011. 332: 243-247.
72. Han, J. M., Wu, D., Denroche, H. C., Yao, Y., Verchere, C. B. and Levings, M. K., IL-33 reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance. J. Immunol. 2015. 194: 4777-4783.
73. Wang, Y., Su, M. A. and Wan, Y. Y., An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 2011. 35: 337-348.
74. Hayakawa, M., Yanagisawa, K., Aoki, S., Hayakawa, H., Takezako, N. and Tominaga, S., T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3. Biochim. Biophys. Acta 2005. 1728: 53-64.
75. Bapat, S. P., Myoung Suh, J., Fang, S., Liu, S., Zhang, Y., Cheng, A., Zhou, C. et al., Depletion of fat-resident T cells prevents age-associated insulin resistance. Nature 2015. 528: 137-141.
76. Brestoff, J. R., Kim, B. S., Saenz, S. A., Stine, R. R., Monticelli, L. A., Sonnenberg, G. F., Thome, J. J. et al., Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015. 519: 242-246.
77. Hams, E., Locksley, R. M., McKenzie, A. N. and Fallon, P. G., Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J. Immunol. 2013. 191: 5349-5353.
78. Qiu, Y., Nguyen, K. D., Odegaard, J. I., Cui, X., Tian, X., Locksley, R. M., Palmiter, R. D. et al., Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014. 157: 1292-1308.
79. Grobeta, P., Doser, K., Falk, W., Obermeier, F. and Hofmann, C., IL-33 attenuates development and perpetuation of chronic intestinal inflammation. Inflamm. Bowel Dis. 2012. 18: 1900-1909.
80. Schiering, C., Krausgruber, T., Chomka, A., Frohlich, A., Adelmann, K., Wohlfert, E. A., Pott, J. et al., The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014. 513: 564-568.
81. Arpaia, N., Green, J. A., Moltedo, B., Arvey, A., Hemmers, S., Yuan, S., Treuting, P. M. and Rudensky, A. Y., A distinct function of regulatory T cells in tissue protection. Cell 2015. 162: 1078-1089.
82. Monticelli, L. A., Osborne, L. C., Noti, M., Tran, S. V., Zaiss, D. M. and Artis, D., IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc. Natl. Acad. Sci. USA 2015. 112: 10762-10767.
83. Zaiss, D. M., van Loosdregt, J., Gorlani, A., Bekker, C. P., Grone, A., Sibilia, M., van Bergen en Henegouwen, P. M. et al., Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Immunity 2013. 38: 275-284.
84. Maywald, R. L., Doerner, S. K., Pastorelli, L., De Salvo, C., Benton, S. M., Dawson, E. P., Lanza, D. G. et al., IL-33 activates tumor stroma to promote intestinal polyposis. Proc. Natl. Acad. Sci. USA 2015. 112: E2487-E2496.
85. Mager, L. F., Riether, C., Schurch, C. M., Banz, Y., Wasmer, M. H., Stuber, R., Theocharides, A. P. et al., IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J. Clin. Invest. 2015. 125: 2579-2591.
86. Kim, J. Y., Lim, S. C., Kim, G., Yun, H. J., Ahn, S. G. and Choi, H. S., Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity. Oncogene 2015. 34: 4928-4938.
87. Jovanovic, I. P., Pejnovic, N. N., Radosavljevic, G. D., Pantic, J. M., Milovanovic, M. Z., Arsenijevic, N. N. and Lukic, M. L., Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells. Int. J. Cancer 2014. 134: 1669-1682.
88. Yu, X. X., Hu, Z., Shen, X., Dong, L. Y., Zhou, W. Z. and Hu, W. H., IL-33 promotes gastric cancer cell invasion and migration via ST2-ERK1/2 pathway. Dig. Dis. Sci. 2015. 60: 1265-1272.
89. Tong, X., Barbour, M., Hou, K., Gao, C., Cao, S., Zheng, J., Zhao, Y. et al., Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways. Mol. Oncol. 2016. 10(1): 113-125.
90. Kim, M. S., Kim, E., Heo, J. S., Bae, D. J., Lee, J. U., Lee, T. H., Lee, H. J. et al., Circulating IL-33 level is associated with the progression of lung cancer. Lung Cancer 2015. 90: 346-351.
91. Ishikawa, K., Yagi-Nakanishi, S., Nakanishi, Y., Kondo, S., Tsuji, A., Endo, K., Wakisaka, N. et al., Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue. Auris Nasus Larynx 2014. 41: 552-557.
92. Gao, X., Wang, X., Yang, Q., Zhao, X., Wen, W., Li, G., Lu, J. et al., Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells. J. Immunol. 2015. 194: 438-445.
93. Gao, K., Li, X., Zhang, L., Bai, L., Dong, W., Gao, K., Shi, G. et al., Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice. Cancer Lett. 2013. 335: 463-471.
94. Villarreal, D. O. and Weiner, D. B., IL-33 isoforms: their future as vaccine adjuvants? Expert Rev. Vaccines 2015. 14: 489-492.
95. Guex, N., Peitsch, M. C. and Schwede, T., Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 2009. 30 Suppl 1: S162-S173.